BARDDS

BARDDS

Buenos Aires Registry for Drug Delivery Stents. An Argentine study describing early experience with the Quanam drug-eluting stent.
 
Conclusion
All QuaDS-QP-2 stents were angiographically and IVUS patent; reinterventions were required in 2 of 32 treated patients due to new disease or distal small-vessel disease beyond the stent.